In addition, in a study of 18 breast cancer patients and 11 healthy controls, the serum MMP-14 levels determined using an enzyme-linked immunosorbent assay were significantly higher in cancer patients than in controls [23]. This evidence concerns the gene MMP14 and breast carcinoma.